DCM
XERS icon

Driehaus Capital Management’s Xeris Biopharma Holdings XERS Stock Holding History

Driehaus Capital Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.24M Sell
902,740
-2,077,827
-70% -$13.8M 0.04% 289
2025
Q4 		$23.4M Buy
2,980,567
+361,438
+14% +$2.84M 0.16% 183
2025
Q3 		$21.3M Buy
2,619,129
+548,054
+26% +$3.64M 0.15% 195
2025
Q2 		$9.67M Buy
2,071,075
+659,535
+47% +$3.02M 0.08% 259
2025
Q1 		$7.75M Buy
1,411,540
+817,525
+138% +$3.3M 0.07% 272
2024
Q4 		$2.01M Buy
+594,015
New +$1.91M 0.02% 311

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Driehaus Capital Management's XERS Position: Q1 2026 in Review

Driehaus Capital Management reduced its Xeris Biopharma Holdings (XERS) stake by 70% in Q1 2026, selling an estimated $13.8M and leaving 902,740 shares worth $5.24M. The position accounts for 0.04% of the portfolio, ranked #289.

Driehaus Capital Management first reported a position in XERS in Q4 2024 and has held it in 6 quarters since. The position peaked at $23.4M in Q4 2025. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • Driehaus Capital Management held 902,740 shares of Xeris Biopharma Holdings worth $5.24M as of Q1 2026.
  • Driehaus Capital Management sold 2,077,827 Xeris Biopharma Holdings shares in Q1 2026, an estimated $13.8M.
  • Xeris Biopharma Holdings made up 0.04% of Driehaus Capital Management's portfolio in Q1 2026, its #289 holding.
  • Driehaus Capital Management first reported a position in Xeris Biopharma Holdings in Q4 2024 and has held it in 6 quarters since.
  • Driehaus Capital Management's Xeris Biopharma Holdings position peaked at $23.4M in Q4 2025.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on Driehaus Capital Management's 13F filing for Q1 2026, filed 15 May 2026.